Lang T, Nicaud V, Darné B, Rueff B
INSERM U258, Hôpital Broussais, Paris, France.
J Epidemiol Community Health. 1995 Dec;49(6):610-6. doi: 10.1136/jech.49.6.610.
To improve blood pressure control among hypertensive ( > 140/90 mmHg) excessive alcohol drinkers.
Fourteen worksite physicians were randomised onto an intervention group and a control group. The intervention was based on training the worksite physicians and follow up of those hypertensive subjects defined as excessive drinkers. Follow up was based on self monitoring of alcohol consumption by the subject, in view of the results of their gamma glutamyl transferase (GGT) activity determination.
Fourteen workplaces in France - mainly in the industrial sector.
Altogether 15 301 subjects were screened by the 14 physicians: 129 of these were included in the study.
This was the difference between the initial systolic blood pressure (SBP) and the SBP one year later (delta BP). Secondary criteria were the difference between the initial and final diastolic blood pressure (delta DBP) and delta BP at two years; antihypertensive treatment; state alcohol consumption (delta AC); delta GGT; and body mass index (delta BMI).
The decrease in SBP levels was significantly larger in the intervention group than in the control group: at one year, delta SBP values were -11.9 (15.6) mmHg and -4.6 (13.8) respectively (p < 0.05). This benefit was still observed after two years of follow up (-13.8 (17.4) mmHg v -7.5 (14.2) mmHg (p < 0.05)). No difference was observed in DBP. The percentage of treated subjects did not differ between groups. At one year, delta AC was larger in the intervention group (-2.8 (5.2) U/d) than in the control group (-1.6 (3.4) (p < 0.1)). delta GGT and delta BMI did not differ between the two groups. A weak positive correlation was observed between delta AC and delta SBP (r = 0.16).
An intervention aimed at the hypertensive excessive drinkers in a working population was found to be effective in reducing SBP on a long term basis (two years). The mechanisms of reduction in alcohol consumption and improved drug compliance cannot be ascertained in this pragmatic study. From a public health point of view, reducing the excess cardiovascular risk among a "hard to reach" population seems feasible with a strategy specifically designed for this high risk group.
改善高血压(收缩压>140mmHg和舒张压>90mmHg)且过度饮酒者的血压控制情况。
14名企业医生被随机分为干预组和对照组。干预措施基于对企业医生的培训以及对那些被定义为过度饮酒者的高血压患者进行随访。随访基于受试者对酒精摄入量的自我监测,并参考其γ-谷氨酰转移酶(GGT)活性测定结果。
法国的14个工作场所——主要是工业领域。
14名医生共筛查了15301名受试者,其中129名被纳入研究。
这是初始收缩压(SBP)与一年后的SBP之间的差值(血压差值)。次要标准包括初始舒张压与最终舒张压之间的差值(舒张压差值)以及两年时的血压差值;抗高血压治疗情况;酒精摄入量变化(酒精摄入量差值);GGT变化;以及体重指数变化(体重指数差值)。
干预组SBP水平的下降幅度显著大于对照组:一年时,SBP差值分别为-11.9(15.6)mmHg和-4.6(13.8)mmHg(p<0.05)。随访两年后仍观察到这种益处(-13.8(17.4)mmHg对-7.5(14.2)mmHg(p<0.05))。舒张压方面未观察到差异。两组接受治疗的受试者百分比无差异。一年时,干预组的酒精摄入量差值(-2.8(5.2)单位/天)大于对照组(-1.6(3.4))(p<0.1)。两组之间GGT变化和体重指数变化无差异。酒精摄入量差值与SBP之间观察到弱正相关(r=0.16)。
针对在职人群中高血压且过度饮酒者实施的干预措施被发现可长期(两年)有效降低收缩压。在这项实用性研究中,无法确定酒精摄入量减少和药物依从性改善的机制。从公共卫生角度来看,通过专门为这一高危群体设计的策略来降低“难以触及”人群中过高的心血管疾病风险似乎是可行的。